Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.5.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.5.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.503NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.623NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.588NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.210NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.567NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.541NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.189NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.563NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.258NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.426NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.399NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.337NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.539NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.164NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.392NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.377NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BB.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HH.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.22.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-21208.1South Korea
GY.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HW.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used